Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2001
12/19/2001CN1326949A New polypeptide-human visinin analogous protein 17.27 and polynucleotide for encoding such polypeptide
12/19/2001CN1326948A New polypeptide-human sigma receptor 10.67 and polynucleotide for encoding such polypeptide
12/19/2001CN1326947A Human thymosin alpha protogene mutant synthesis, expression and use
12/19/2001CN1326946A New polypeptide-ribosomal protein S1111.22 and polynucleotide for encoding such polypeptide
12/19/2001CN1326945A New polypeptide-zinc finger protein 79.46 and polynucleotide for encoding such polypeptide
12/19/2001CN1326944A New polypeptide-symplekin 8.91 and polynucleotide for encoding such polypeptide
12/19/2001CN1326943A New polypeptide-conjugated protein Ran BP236.85 and polynucleotide for encoding such polypeptide
12/19/2001CN1326942A New polypeptide-CREB conjugated protein 30.8 and polynucleotide for encoding such polypeptide
12/19/2001CN1326941A New polypeptide-estrogenic receptor relative protein 9,13 and polynucleotide for encoding such polypeptide
12/19/2001CN1326940A New polypeptide-ribosomal protein S13, 09 and polynuclotide for encoding such polypeptide
12/19/2001CN1326938A Antigene V-erb B oligonucleotide and its use
12/19/2001CN1326782A About human digestive enzyme recombined protein and its preparing method
12/19/2001CN1076397C Process for preparing mycobacterium primers and probes
12/19/2001CN1076356C Protein having TPO activity
12/19/2001CN1076204C Recombinant coccidiosis vaccines
12/18/2001US6331665 Insect resistant fertile transgenic corn plants
12/18/2001US6331664 Genes, when expressed in a plant, can be used to create transgenic plants having altered palmitic acid oil profiles
12/18/2001US6331663 Modified full length promoters
12/18/2001US6331662 Plant retroelements
12/18/2001US6331661 Method for directional stable transformation of eukaryotic cells
12/18/2001US6331660 Maize DIMBOA biosynthesis genes
12/18/2001US6331659 Cumulus cells as nuclear donors
12/18/2001US6331658 Genetically engineered mammals for use as organ donors
12/18/2001US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis
12/18/2001US6331618 For analytical methods such as gel electrophoresis, high-performance liquid chromatography, primer extension reactions, polymerase chain reaction (pcr), mass spectroscopy, nuclear magnetic resonance (nmr) and x-ray crystallization
12/18/2001US6331617 Positively charged oligonucleotides as regulators of gene expression
12/18/2001US6331616 Nucleotide sequences coding viral envelope protein; for use as diagnostic tool in detection of viral infection
12/18/2001US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration
12/18/2001US6331612 Bone morphogenic protein-16 (BMP-16) compositions
12/18/2001US6331609 Fusion protein; for use in treatment of somatotropin defects
12/18/2001US6331527 Promoter smooth muscle cell expression
12/18/2001US6331526 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides
12/18/2001US6331525 Targeted delivery of genes encoding interferon
12/18/2001US6331524 Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy
12/18/2001US6331441 For high throughput analysis of multiple analytes in complex mixtures of sample substances, combinatorial analysis
12/18/2001US6331434 Nitrogen-containing silicone useful for compacting nucleic acid sequences and use for transforming cells
12/18/2001US6331433 Human T cell leukemia cell line designated D1.1
12/18/2001US6331427 Protease homologs
12/18/2001US6331425 Nucleotide sequences coding enzymatic polypeptide; for use in the diagnosis and treatment of cancer, meningitis and urogenital disorders; for sequencing preferential oligosaccharides
12/18/2001US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity
12/18/2001US6331421 Expression vector for use as tool for efficient generation of preferential enzymatic polypeptides
12/18/2001US6331419 L-glutamic acid-producing bacterium and method for producing L-glutamic acid
12/18/2001US6331417 Determine amount of target nucleotide sequences in sample; mix sample with control sequences, incubate with nucleotide sequences, perform nucleotide sequence amplification, calculate amount of control and target sequences
12/18/2001US6331416 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/18/2001US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein
12/18/2001US6331414 Preparation of human IGF via recombinant DNA technology
12/18/2001US6331411 TopA
12/18/2001US6331410 Polynucleotides encoding a novel pyrR homolog
12/18/2001US6331406 Human enbryonic germ cell and methods of use
12/18/2001US6331399 For therapeutic, diagnostic, and research applications for the modulation of telomer reverse transcriptase expression
12/18/2001US6331398 Nucleic acid ligands
12/18/2001US6331397 Method for producing long DNA constructs in agarose
12/18/2001US6331393 Detecting cytosine methylation and methylated cytosine/guanine aggregations; incubate genomic nucleotide sequences adjusting agent, amplify nucleotide sequences, detecting the methylated nucleotide sequences
12/18/2001US6331392 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids
12/18/2001US6331390 Cell-cycle regulatory proteins, and uses related thereto
12/18/2001US6331304 Immunogenic composition comprising an attenuated form which is a strain of leishmania and which is transformed by a plasmid containing the gm-csf gene
12/18/2001US6331303 LKTA deletion mutant of P. haemolytica
12/18/2001US6331301 Isolated dna sequences which encodes amino acid sequence in protein;
12/18/2001US6331140 Mobile genetic elements as tools for genetic modification of L. delbrueckii or L. helveticus
12/18/2001CA2221448C Antisense oligonucleotide modulation of raf gene expression
12/18/2001CA2215531C Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases
12/18/2001CA2209298C Mpl ligand analogs
12/18/2001CA2201762C Method for purifying keratinocyte growth factors
12/18/2001CA2179281C Methods of identifying lymphocytes with mutator phenotypes
12/18/2001CA2134478C Microfabricated detection structures
12/18/2001CA2125004C Simultaneous amplification of multiple targets
12/18/2001CA2088661C Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases
12/18/2001CA2045839C Cloned n-methylhydantoinase
12/16/2001CA2350976A1 Cell libraries indexed to nucleic acid microarrays
12/14/2001CA2309342A1 Protein production in transgenic plant seeds
12/13/2001WO2001094952A2 Methods and compositions for modulating oxidized ldl transport
12/13/2001WO2001094951A2 Inhibitors of c-reactive protein induced inflammation
12/13/2001WO2001094950A2 Screening of phage displayed peptides without clearing of the cell culture
12/13/2001WO2001094946A2 Microarrays for performing proteomic analyses
12/13/2001WO2001094638A2 Asynchronous primed pcr
12/13/2001WO2001094636A2 Compositions, kits, and methods for identification and modulation of type i diabetes
12/13/2001WO2001094635A2 Integrated active flux microfluidic devices and methods
12/13/2001WO2001094634A2 Methods and devices for multiplexing amplification reactions
12/13/2001WO2001094633A1 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods
12/13/2001WO2001094630A2 Compositions and methods for array-based nucleic acid hybridization
12/13/2001WO2001094629A2 Cancer gene determination and therapeutic screening using signature gene sets
12/13/2001WO2001094627A2 Assay techniques based on growth stage dependent expression in c. elegans
12/13/2001WO2001094625A2 Capture moieties for nucleic acids and uses thereof
12/13/2001WO2001094624A1 Method to detect modulators of vegf kinase domain
12/13/2001WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase
12/13/2001WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability
12/13/2001WO2001094617A2 Protein fragment complementation assay based on beta-lactamase
12/13/2001WO2001094616A1 Protein markers for pharmaceuticals and related toxicity
12/13/2001WO2001094610A2 Binary hybrid mutational vectors
12/13/2001WO2001094609A1 Charge-switch nucleotides
12/13/2001WO2001094607A2 High level production of p-hydroxybenzoic acid in green plants
12/13/2001WO2001094604A2 Method of using dna episomes to suppress gene expression in plants
12/13/2001WO2001094603A2 Method of using dna episomes to suppress gene expression in plants
12/13/2001WO2001094602A2 Method to regenerate plants and uses thereof to multiply and/or transform plants
12/13/2001WO2001094601A2 Hero resistance gene conferring resistance to nematodes
12/13/2001WO2001094600A2 Promoters for regulated gene expression
12/13/2001WO2001094599A1 Gene expression cassette and its use
12/13/2001WO2001094598A2 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells
12/13/2001WO2001094597A1 Purified proenzyme of dipeptidyl peptidase i (pro-dppi)